- Report
- November 2024
- 150 Pages
Global
From €4650EUR$4,850USD£3,885GBP
- Report
- August 2024
- 150 Pages
Global
From €4650EUR$4,850USD£3,885GBP
- Report
- August 2024
- 112 Pages
Global
From €4314EUR$4,500USD£3,605GBP
- Report
- August 2024
- 62 Pages
Global
From €4314EUR$4,500USD£3,605GBP
- Report
- July 2024
- 127 Pages
Global
From €4314EUR$4,500USD£3,605GBP
- Report
- January 2025
- 180 Pages
Global
From €4314EUR$4,500USD£3,605GBP
- Report
- January 2025
- 141 Pages
Global
From €3787EUR$3,950USD£3,164GBP
- Report
- December 2024
- 146 Pages
Global
From €3787EUR$3,950USD£3,164GBP
- Report
- March 2025
- 150 Pages
Global
From €4650EUR$4,850USD£3,885GBP
- Report
- December 2024
- 200 Pages
Global
From €3595EUR$3,750USD£3,004GBP
- Report
- December 2024
- 200 Pages
Global
From €3595EUR$3,750USD£3,004GBP
- Report
- December 2024
- 200 Pages
Global
From €3595EUR$3,750USD£3,004GBP
- Report
- October 2024
- 200 Pages
Global
From €3595EUR$3,750USD£3,004GBP
- Report
- October 2024
- 200 Pages
Global
From €3595EUR$3,750USD£3,004GBP
- Report
- October 2024
- 200 Pages
Global
From €3595EUR$3,750USD£3,004GBP
- Report
- October 2024
- 200 Pages
Global
From €3595EUR$3,750USD£3,004GBP
From €3451EUR$3,600USD£2,884GBP
- Report
- October 2024
- 200 Pages
Global
From €4744EUR$4,949USD£3,964GBP
- Report
- August 2024
- 200 Pages
Global
From €3709EUR$3,869USD£3,099GBP
- Report
- May 2024
- 140 Pages
Global
From €4744EUR$4,949USD£3,964GBP

The Biomarkers market is a sector of the healthcare industry that focuses on the development and use of biomarkers for the diagnosis, prognosis, and treatment of diseases. Biomarkers are biological molecules that can be used to measure the presence or absence of a disease, or to monitor the progression of a disease. They can also be used to predict the response to a particular treatment. Biomarkers are typically proteins, nucleic acids, or metabolites that are found in the body and can be measured in a variety of ways.
Biomarkers are used in a variety of medical applications, including cancer diagnosis and treatment, cardiovascular disease, and neurological disorders. They are also used in drug development, to identify potential drug targets and to monitor the safety and efficacy of drugs.
Some of the major companies in the Biomarkers market include Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, Roche, and Sanofi. Show Less Read more